Novartis Bioventures Ltd, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), sold 340,976 shares at $1.09 ($367K) on 2019-04-10, disclosed to the SEC on 2019-04-10.
Open-market sale of $367k ARPO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.02 | 27,525 | $28K | 7.6% |
| 2 | $1.01 | 32,991 | $33K | 9.1% |
| 3 | $1.09 | 140,230 | $153K | 41.6% |
| 4 | $1.09 | 140,230 | $153K | 41.6% |
| Total | $1.08 avg | 340,976 | $367K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |